Folgen
Peter Hein
Peter Hein
TherapeutAix
Bestätigte E-Mail-Adresse bei therapeutaix.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Dynamics of receptor/G protein coupling in living cells
P Hein, M Frank, C Hoffmann, MJ Lohse, M Bünemann
The EMBO journal 24 (23), 4106-4114, 2005
2712005
Gs activation is time-limiting in initiating receptor-mediated signaling
P Hein, F Rochais, C Hoffmann, S Dorsch, VO Nikolaev, S Engelhardt, ...
Journal of Biological Chemistry 281 (44), 33345-33351, 2006
1702006
Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors
MJ Lohse, VO Nikolaev, P Hein, C Hoffmann, JP Vilardaga, M Bünemann
Trends in pharmacological sciences 29 (3), 159-165, 2008
1572008
Kinetics of G‐protein‐coupled receptor signals in intact cells
MJ Lohse, P Hein, C Hoffmann, VO Nikolaev, JP Vilardaga, M Bünemann
British journal of pharmacology 153 (S1), S125-S132, 2008
1332008
Signal transduction underlying carbachol-induced contraction of rat urinary bladder. I. Phospholipases and Ca2+ sources
T Schneider, P Hein, MC Michel
Journal of Pharmacology and Experimental Therapeutics 308 (1), 47-53, 2004
1012004
Coupling mode of receptors and G proteins
P Hein, M Bünemann
Naunyn-Schmiedeberg's archives of pharmacology 379, 435-443, 2009
722009
Signal transduction and regulation: Are all α1-adrenergic receptor subtypes created equal?
P Hein, MC Michel
Biochemical pharmacology 73 (8), 1097-1106, 2007
722007
Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder
T Schneider, P Hein, MB Michel-Reher, MC Michel
Naunyn-Schmiedeberg's archives of pharmacology 372, 71-78, 2005
592005
Comparison of the activation kinetics of the M3 acetylcholine receptor and a constitutively active mutant receptor in living cells
C Hoffmann, S Nuber, U Zabel, N Ziegler, C Winkler, P Hein, CH Berlot, ...
Molecular pharmacology 82 (2), 236-245, 2012
452012
Receptor and binding studies
P Hein, MC Michel, K Leineweber, T Wieland, N Wettschureck, ...
Practical methods in cardiovascular research, 723-783, 2005
392005
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α1A- vs. α1B- and α1D-adrenoceptors
M Eltze, R Boer, MC Michel, P Hein, R Testa, WR Ulrich, N Kolassa, ...
Naunyn-Schmiedeberg's Archives of Pharmacology 363, 649-662, 2001
372001
A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction?
T Schneider, P Hein, J Bai, MC Michel
The Journal of urology 173 (6), 2178-2181, 2005
362005
Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine
C Altmann, V Steenpaß, P Czyborra, P Hein, MC Michel
British journal of pharmacology 138 (1), 261, 2003
252003
i2- and Gαi3-Specific Regulation of Voltage-Dependent L-Type Calcium Channels in Cardiomyocytes
S Dizayee, S Kaestner, F Kuck, P Hein, C Klein, RP Piekorz, J Meszaros, ...
PloS one 6 (9), e24979, 2011
232011
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster α1B-adrenoceptors
P Hein, M Goepel, S Cotecchia, MC Michel
Naunyn-Schmiedeberg's archives of pharmacology 363, 34-39, 2001
232001
Validity of the cold pressor test and pain sensitivity questionnaire via online self-administration
MH McIntyre, 23andMe Research Team, A Kless, P Hein, M Field, ...
PloS one 15 (4), e0231697, 2020
192020
Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis–effects of a peroxisome proliferator-activated receptor gamma …
SJ Daniels, DJ Leeming, S Detlefsen, MF Bruun, ST Hjuler, K Henriksen, ...
Biomedicine & Pharmacotherapy 111, 926-933, 2019
172019
A systematic review of inverse agonism at adrenoceptor subtypes
MC Michel, MB Michel-Reher, P Hein
Cells 9 (9), 1923, 2020
152020
The future R&D landscape in non-alcoholic steatohepatitis (NASH)
D Black, S Brockbank, S Cruwys, K Goldenstein, P Hein, B Humphries
Drug discovery today 24 (2), 560-566, 2019
132019
Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities
S Cruwys, P Hein, B Humphries, D Black
Drug Discovery Today 25 (12), 2277-2283, 2020
112020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20